Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
90.92 CHF | -0.21% | -2.54% | +6.98% |
May. 27 | Novartis: positive phase III results in C3G | CF |
May. 27 | Novartis: presented results for kidney disease | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.98% | 204B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.38% | 238B | |
-6.46% | 203B | |
+4.23% | 161B | |
-1.70% | 160B | |
-1.76% | 120B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Sector Update: Health Care Stocks Softer Late Afternoon